Co-Diagnostics, Inc. Reports Its COVID-19 PCR Assays Unaffected by Omicron Variant
Co-Diagnostics, Inc. has reported that none of the mutations in the Omicron SARS-CoV-2 variant will interfere with any of the company’s COVID-19 tests.
Read More
Search Results for: point-of-care
BioReference Laboratories Prepared for COVID-19 Testing of the Omicron Variant
BioReference Laboratories, Inc., an OPKO Health company, has announced that it is prepared for COVID-19 testing for the Omicron Variant.
Read More
New Schistosomiasis Diagnostic Testing May Lead to its Eradication
Researchers have made progress toward a new diagnostic test for schistosomiasis which could help achieve interrupting transmission of the disease.
Read More
Essenlix, Roche Norway Wins for Patient At-Home Testing Solution
Essenlix Corporation, in partnership with Roche Norway, has won Norway Østfold Hospital System’s “Patient At-Home Test” Innovation Partnership.
Read More
EKF Diagnostics Acquires Molecular Diagnostic Testing Laboratory
EKF Diagnostics announces that it has acquired Advanced Diagnostic Laboratory LLC, a Texas based PCR-focused testing laboratory.
Read More